rainer wrote:bigger market for MS = more money into MS research
I really wish it worked that way but it just doesn't. The vast majority of grass roots MS research is done in the universities and if they discover something that may become viable ( big profit)for a drug company to pursue, then the company will take over the continuation of the research. (usually clinical trials for long term drug therapy use.)
Any discovery that can't be patetented will remain in the shadows with little funding to pursue its development. That's just the way it is!